Package 0276-0500-10
Brand: chlordiazepoxide hydrochloride and clidinium bromide
Generic: chlordiazepoxide hydrochloride, clidinium bromidePackage Facts
Identity
Package NDC
0276-0500-10
Digits Only
0276050010
Product NDC
0276-0500
Description
100 CAPSULE in 1 BOTTLE (0276-0500-10)
Marketing
Marketing Status
Brand
chlordiazepoxide hydrochloride and clidinium bromide
Generic
chlordiazepoxide hydrochloride, clidinium bromide
Sample Package
No
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "4139e8c6-5256-6934-e063-6294a90aa5a0", "openfda": {"unii": ["MFM6K1XWDK", "91ZQW5JF1Z"], "rxcui": ["889614"], "spl_set_id": ["a42fc981-77bc-4c9e-a79d-b821bffb65b4"], "manufacturer_name": ["Misemer Pharmaceuticals, Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE in 1 BOTTLE (0276-0500-10)", "package_ndc": "0276-0500-10", "marketing_start_date": "20200903"}], "brand_name": "Chlordiazepoxide Hydrochloride and Clidinium Bromide", "product_id": "0276-0500_4139e8c6-5256-6934-e063-6294a90aa5a0", "dosage_form": "CAPSULE", "pharm_class": ["Anticholinergic [EPC]", "Benzodiazepine [EPC]", "Benzodiazepines [CS]", "Cholinergic Antagonists [MoA]", "Decreased Parasympathetic Acetylcholine Activity [PE]", "Digestive/GI System Activity Alteration [PE]", "GI Motility Alteration [PE]"], "product_ndc": "0276-0500", "dea_schedule": "CIV", "generic_name": "Chlordiazepoxide Hydrochloride, Clidinium Bromide", "labeler_name": "Misemer Pharmaceuticals, Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Chlordiazepoxide Hydrochloride and Clidinium Bromide", "active_ingredients": [{"name": "CHLORDIAZEPOXIDE HYDROCHLORIDE", "strength": "5 mg/1"}, {"name": "CLIDINIUM BROMIDE", "strength": "2.5 mg/1"}], "application_number": "ANDA210579", "marketing_category": "ANDA", "marketing_start_date": "20200903", "listing_expiration_date": "20261231"}